BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pei WG, Chen WZ, Wu YK, Tan SX, Jie ZG. Immune-related adverse events associated with immune checkpoint inhibitors for advanced gastric and gastroesophageal junction cancer: A meta-analysis. World J Gastrointest Oncol 2023; 15(2): 352-367 [PMID: 36908315 DOI: 10.4251/wjgo.v15.i2.352]
URL: https://www.wjgnet.com/1948-5204/full/v15/i2/352.htm
Number Citing Articles
1
Hyung-Don Kim, Jinho Shin, Jaewon Hyung, Hyungeun Lee, Meesun Moon, Jeongeun Ma, Young Soo Park, Min-Hee Ryu. Survival outcomes of patients with gastric cancer treated with first-line nivolumab plus chemotherapy based on claudin 18.2 expressionGastric Cancer 2025; 28(1): 74 doi: 10.1007/s10120-024-01566-7
2
Hui Yuan, Miao Bao, Minqiang Chen, Junhao Fu, Shian Yu. Advances in Immunotherapy and Targeted Therapy for Gastric Cancer: A Comprehensive ReviewBritish Journal of Hospital Medicine 2025; 86(3): 1 doi: 10.12968/hmed.2024.0759